|
|
|
Insider
Information: |
Cha Albert |
Relationship: |
Director |
City: |
Danbury |
State: |
CT |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
318 |
|
Indirect Shares
|
9,808,173 |
|
|
Direct
Value |
$14,040 |
|
|
Indirect Value
|
$221,465,765 |
|
|
Total
Shares |
9,808,491 |
|
|
Total
Value |
$221,479,805 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
1
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
Percentage
Gain/Loss : |
23.0%
|
6.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Albireo Pharma Inc |
ALBO |
Director |
2007-05-16 |
318 |
2008-02-12 |
1,553,632 |
Premium* |
|
Kalvista Pharmaceuticals Inc |
KALV |
Director |
2023-09-11 |
0 |
2020-10-30 |
1,138,179 |
Premium* |
|
Sierra Oncology Inc |
SRRA |
Director |
2015-07-21 |
0 |
2015-07-21 |
2,438,270 |
Premium* |
|
Aclaris Therapeutics, Inc. |
ACRS |
Director |
|
0 |
2015-10-13 |
4,191,397 |
Premium* |
|
VYNE Therapeutics Inc |
VYNE |
Director |
2018-01-25 |
0 |
2018-01-29 |
486,695 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KALV |
Kalvista Pharmaceuticals ... |
Director |
|
2019-07-19 |
4 |
B |
$17.68 |
$1,068,581 |
I/I |
60,000 |
975,821 |
2.1 |
- |
|
KALV |
Kalvista Pharmaceuticals ... |
Director |
|
2020-10-30 |
4 |
B |
$17.17 |
$1,994,068 |
I/I |
115,686 |
1,138,179 |
2.1 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
Director |
|
2019-07-29 |
4 |
B |
$17.13 |
$511,702 |
I/I |
29,867 |
124,566 |
2.1 |
- |
|
SRRA |
Sierra Oncology Inc |
Director |
|
2015-07-21 |
4 |
B |
$17.00 |
$3,740,000 |
I/I |
220,000 |
2,438,270 |
2.1 |
- |
|
VYNE |
VYNE Therapeutics Inc |
Director |
|
2018-01-25 |
4 |
B |
$17.00 |
$5,000,006 |
I/I |
294,118 |
35,686 |
2.1 |
- |
|
KALV |
Kalvista Pharmaceuticals ... |
Director |
|
2018-09-10 |
4 |
B |
$17.00 |
$18,000,008 |
I/I |
1,058,824 |
1,359,149 |
2.1 |
- |
|
KALV |
Kalvista Pharmaceuticals ... |
Director |
|
2019-07-17 |
4 |
B |
$16.93 |
$21,715 |
I/I |
1,280 |
104,551 |
2.1 |
- |
|
KALV |
Kalvista Pharmaceuticals ... |
Director |
|
2019-07-26 |
4 |
B |
$16.83 |
$446,035 |
I/I |
26,500 |
997,763 |
2.1 |
- |
|
ALBO |
Albireo Pharma Inc |
Director |
|
2008-02-12 |
4 |
S |
$15.50 |
$2,046,000 |
I/I |
(132,000) |
1,553,632 |
0 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
Director |
|
2015-10-07 |
4 |
B |
$11.00 |
$146,872 |
I/I |
13,352 |
303,206 |
2.1 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
Director |
|
2015-10-13 |
4 |
B |
$11.00 |
$4,999,995 |
I/I |
454,545 |
4,191,397 |
2.1 |
- |
|
KALV |
Kalvista Pharmaceuticals ... |
Director |
|
2023-09-11 |
4 |
S |
$10.50 |
$189,050 |
D/D |
(18,000) |
0 |
0 |
% |
|
KALV |
Kalvista Pharmaceuticals ... |
Director |
|
2023-09-11 |
4 |
OE |
$6.71 |
$134,820 |
D/D |
18,000 |
18,000 |
0 |
- |
|
SRRA |
Sierra Oncology Inc |
Director |
|
2015-07-21 |
4 |
A |
$5.22 |
$568,284 |
I/I |
108,971 |
2,218,270 |
0 |
- |
|
KALV |
Kalvista Pharmaceuticals ... |
Director |
|
2015-04-14 |
4 |
B |
$5.00 |
$5,062,500 |
I/I |
1,012,500 |
4,204,564 |
2.1 |
- |
|
KALV |
Kalvista Pharmaceuticals ... |
Director |
|
2015-04-14 |
4/A |
B |
$5.00 |
$5,062,500 |
I/I |
1,012,500 |
4,204,562 |
2.1 |
- |
|
ALBO |
Albireo Pharma Inc |
Director |
|
2007-05-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,078,933 |
1,685,632 |
0 |
- |
|
KALV |
Kalvista Pharmaceuticals ... |
Director |
|
2015-04-14 |
4/A |
A |
$0.00 |
$0 |
I/I |
3,192,062 |
3,192,062 |
0 |
- |
|
KALV |
Kalvista Pharmaceuticals ... |
Director |
|
2015-04-14 |
4 |
A |
$0.00 |
$0 |
I/I |
3,192,064 |
3,192,064 |
0 |
- |
|
SRRA |
Sierra Oncology Inc |
Director |
|
2015-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
2,109,299 |
2,109,299 |
0 |
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
Director |
|
2015-10-13 |
4 |
A |
$0.00 |
$0 |
I/I |
3,433,646 |
3,736,852 |
0 |
- |
|
VYNE |
VYNE Therapeutics Inc |
Director |
|
2018-01-29 |
4 |
A |
$0.00 |
$0 |
I/I |
3,717,118 |
486,695 |
0 |
- |
|
ALBO |
Albireo Pharma Inc |
Director |
|
2007-05-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
606,699 |
|
- |
|
ALBO |
Albireo Pharma Inc |
Director |
|
2007-05-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
318 |
|
- |
|
ACRS |
Aclaris Therapeutics, Inc... |
Director |
|
2015-10-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
289,854 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|